Torii, Yuka
Morioka, Ichiro
Kakei, Yasumasa
Fujioka, Kazumichi
Kakimoto, Yu
Takahashi, Naoto
Yoshikawa, Tetsushi
Moriuchi, Hiroyuki
Oka, Akira
Ito, Yoshinori
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19gk0110037)
Article History
Received: 16 July 2022
Accepted: 9 January 2023
First Online: 19 January 2023
Declarations
:
: Written informed consent was obtained from the parents or legal guardians of all participants. The clinical trial study was approved by the ethics committee of each hospital (Kobe University Hospital: approval number 190025, October 23, 2019; The University of Tokyo Hospital: approval number 2019031-11DX, December 24, 2019; Nihon University Itabashi Hospital: approval number 3112-1550, December 27, 2019; Fujita Medical University Hospital: approval number D-15, December 27, 2019; Nagoya University Hospital: approval number 312010, January 21, 2020; and Nagasaki University Hospital: approval number I19-004; January 29, 2020) and registered in the Japan Registry of Clinical Trials (identifier: jRCT2051190075). The study comparing the results from plasma samples was approved by the institutional review board of Nagoya University Graduate School of Medicine (permission number: 040411664). This study was carried out in compliance with the Declaration of Helsinki guidelines.
: Not applicable.
: The authors declare that they have no competing interests.